Validation of antibiotic susceptibility testing guidelines in a routine clinical microbiology laboratory exemplifies general key challenges in setting clinical breakpoints

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 3921-3926

  Hombach, Michael ^a   Courvalin, Patrice ^b   Böttger, Erik C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOXITIN; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CITROBACTER KOSERI; CLINICAL LABORATORY; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISK DIFFUSION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; HAFNIA ALVEI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MORGANELLA MORGANII; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA RETTGERI; SERRATIA MARCESCENS; SPECIES DIFFERENCE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS PSEUDOINTERMEDIUS; STAPHYLOCOCCUS SAPROPHYTICUS; WILD TYPE; ANTIBIOTIC RESISTANCE; BACTERIUM; DIFFUSION; DRUG EFFECTS; EUROPE; LABORATORY; META ANALYSIS (TOPIC); MICROBIAL SENSITIVITY TEST; REPRODUCIBILITY; SOFTWARE; STANDARDS;

BACTERIA; DIFFUSION; DRUG RESISTANCE, BACTERIAL; EUROPE; GUIDELINES AS TOPIC; LABORATORIES; META-ANALYSIS AS TOPIC; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; SOFTWARE; SPECIES SPECIFICITY;

EID: 84903210306     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02489-13     Document Type: Article

References (27)

1. Courvalin P. 2008. Can pharmacokinetic-pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance? Clin. Microbiol. Infect. 14:989-994. http://dx.doi.org/10.1111/j.1469-0691.2008.02081.x. (Pubitemid 352748838)
2. European Committee on Antimicrobial Susceptibility Testing. 2009. Breakpoint tables for interpretation of MICs and zone diameters, version 1.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk-test-documents/ EUCAST-breakpoints-v1.0-20091221.pdf. Accessed 18 January 2014.
3. European Committee on Antimicrobial Susceptibility Testing. 2014. Breakpoint tables for interpretation of MICs and zone diameters, version 4.0. http://www.eucast.org/clinical-breakpoints/. Accessed 18 January 2014.
4. European Committee on Antimicrobial Susceptibility Testing. 2014. Rationale documents. http://www.eucast.org/documents/rd/. Accessed 18 January 2014.
5. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI document M 100-S 24. CLSI, Wayne, PA.
6. Hombach M, Bloemberg GV, Bottger EC. 2012. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J. Antimicrob. Chemother. 67: 622-632. http://dx.doi.org/10.1093/jac/dkr524.
7. Hombach M, Wolfensberger A, Kuster SP, Bottger EC. 2013. Influence of clinical breakpoint changes from CLSI 2009 to EUCAST 2011 AST guidelines on multidrug resistance rates of Gram-negative rods. J. Clin. Microbiol. 51:2385-2387. http://dx.doi.org/10.1128/JCM.00921-13.
8. Turnidge J, Paterson DL. 2007. Setting and revising antibacterial susceptibility breakpoints. Clin. Microbiol. Rev. 20:391-408. http://dx.doi.org/10.1128/CMR.00047-06. (Pubitemid 47175010)
9. European Committee on Antimicrobial Susceptibility Testing. 2013. Disk diffusion manual, v. 3.0. http://www.eucast.org/antimicrobial-susceptibility- testing/disk-diffusion-methodology/. Accessed 18 January 2014.
10. Clinical and Laboratory Standards Institute. 2008. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd ed. CLSI document M23-A3. CLSI, Wayne, PA.
11. European Committee on Antimicrobial Susceptibility Testing. 2010. Setting breakpoints for new antimicrobial agents, EUCAST SOP 1.0. http: //www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/EUCAST-SOPs/EUCAST-SOP-1. 0-Setting-breakpoints-new-agents-20100926.pdf. Accessed 18 January 2014.
12. Horng-Jinh C, Kuo-Chang H, Chao-Hsien W. 2006. Determination of sample size in using central limit theorem for Weibull distribution. Inf. Manage. Sci. 17:31-46.
13. European Committee on Antimicrobial Susceptibility Testing. 2014. Zone diameter distributions. http://www.eucast.org/zone-diameter-distributions/. Accessed 18 January 2014.
14. Garcia-Sureda L, Domenech-Sanchez A, Barbier M, Juan C, Gasco J, Alberti S. 2011. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 55: 4742-4747. http://dx.doi.org/10.1128/AAC.00309-11.
15. Wang XD, Cai JC, Zhou HW, Zhang R, Chen GX. 2009. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency. J. Med. Microbiol. 58:1196-1202. http://dx.doi.org/10.1099/jmm.0.008094-0.
16. Woodford N, Dallow JW, Hill RL, Palepou MF, Pike R, Ward ME, Warner M, Livermore DM. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459. http://dx.doi.org/10.1016/j.ijantimicag.2006.11.020. (Pubitemid 46349596)
17. Hombach M, Bottger EC, Roos M. 2013. The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clin. Microbiol. Infect. 19:E59-E71. http://dx.doi.org/10.1111/1469-0691.12090.
18. Winstanley T, Courvalin P. 2011. Expert systems in clinical microbiology. Clin. Microbiol. Rev. 24:515-556. http://dx.doi.org/10.1128/CMR.00061-10.
19. Koeth LM, King A, Knight H, May J, Miller LA, Phillips I, Poupard JA. 2000. Comparison of cation-adjusted Mueller-Hinton broth with IsoSensitest broth for the NCCLS broth microdilution method. J. Antimicrob. Chemother. 46:369-376. http://dx.doi.org/10.1093/jac/46.3.369.
20. Hombach M, Zbinden R, Bottger EC. 2013. Standardisation of disk diffusion results for antibiotic susceptibility testing using the sirscan automated zone reader. BMC Microbiol. 13:225. http://dx.doi.org/10.1186/1471-2180-13-225.
21. Canton E, Peman J, Hervas D, Iniguez C, Navarro D, Echeverria J, Martinez-Alarcon J, Fontanals D, Gomila-Sard B, Buendia B, Torroba L, Ayats J, Bratos A, Sanchez-Reus F, Fernandez-Natal I, FUNGEMYCA Study Group. 2012. Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method. J. Clin. Microbiol. 50:3921-3926. http://dx.doi.org/10.1128/JCM.01730-12.
22. Kronvall G, Kahlmeter G, Myhre E, Galas MF. 2003. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin. Microbiol. Infect. 9:120-132. http://dx.doi.org/10. 1046/j.1469-0691.2003.00546.x. (Pubitemid 36527056)
23. Meletiadis J, Mavridou E, Melchers WJ, Mouton JW, Verweij PE. 2012. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob. Agents Chemother. 56:2524-2529. http://dx.doi.org/10.1128/AAC.05959-11.
24. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. 2011. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. J. Clin. Microbiol. 49: 630-637. http://dx.doi.org/10. 1128/JCM.02161-10.
25. Turnidge J, Kahlmeter G, Kronvall G. 2006. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin. Microbiol. Infect. 12:418-425. http://dx.doi.org/10.1111/j.1469-0691.2006.01377.x.
26. Comité de l'Antibiogramme de la Societe Francaise de Microbiologie. 2013. Recommandations. http://www.sfm-microbiologie.org/. Accessed 18 January 2014.
27. European Committee on Antimicrobial Susceptibility Testing. 2014. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. http://www.eucast.org/resistance- mechanisms/. Accessed 18 January 2014.